Particle size and physical state of the lipid phase are major factors influencing the
permanence of lipid dispersions. Nanostructured lipid carriers (NLC) are a delivery system …

Introduction: Nanoparticles are rapidly developing as drug carriers because of their size-
dependent properties. Lipid nanoparticles (LNPs) are widely employed in drug delivery …

Dry powder inhaler (DPI) products have traditionally comprised a simple formulation of
micronised drug mixed with a carrier excipient, typically lactose monohydrate. The presence …

The traits of lipid biocompatibility and versatility have led to many nano‐and microparticulate
lipid formulations being engineered, over the last two decades, in the form of spheres and …

Introduction: Cosmeceuticals are cosmetic products with biologically active ingredients
purporting to have medical or drug-like benefits. Some cosmeceuticals can act effectively …

E-beam irradiation was studied as a post-harvest treatment for red raspberries (Rubus
idaeus L.). Microbial inactivation (natural microbiota and potential pathogenic bacteria) and …

Lipid nanoparticles are well-known nanocarriers for improved drug delivery. Their
formulation development typically involves three formulations steps. In the first part a …

Introduction: Solid lipid particles were introduced in the early 1990s as an alternative drug
carrier system to emulsions, liposomes and polymeric microparticles. Although lipid …

The controlled release of drugs for pulmonary delivery is a research field which has been so
far rather unexploited but is currently becoming increasingly attractive. The introduction part …

Lipid microparticles (LMs) uncoated or coated with chitosan and containing the
neuroprotective polyphenol resveratrol were developed for its targeting to the brain via nasal …